Skip to main content
Clinical Trials/CTRI/2023/07/055021
CTRI/2023/07/055021
Recruiting
Phase 2

A Clinical Trial To Evaluate The Combined Effect OfEkavimshatika Guggulu And Bala Taila MatravastiIn Sciatica. - NI

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
I
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects of either gender aged between 20 to 60 years.
  • 2\. Subjects presenting with signs and symptoms of Sciatica.
  • 3\. Subjects presenting with SLR grading ? 90 degree.
  • 4\. Subjects who are willing to sign the consent form and agreeing to follow the protocol
  • of the study.

Exclusion Criteria

  • 1\. Pregnant women, lactating mothers and mentally challenged persons.
  • 2\. Sciatica developed due to post\-surgical complications.
  • 3\. Congenital deformity of spine.
  • 4\. Infective conditions and inflammatory conditions of spine.
  • 5\. Vertebral fractures/ known case of IVDP.
  • 6\. Neoplastic conditions of spine.
  • 7 Anarhas of Matravasti

Outcomes

Primary Outcomes

Not specified

Similar Trials